SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Promoting Resources 
to Expand Vaccination, Education, and New Treatments 
for HPV Cancers Act of 2021’’ or the ‘‘PREVENT HPV 
Cancers Act of 2021’’. 
SEC. 2. PREVENTING HPV AND HPV-ASSOCIATED CANCERS; 
REAUTHORIZING JOHANNA’S LAW. 
Section 317P of the Public Health Service Act (42 
U.S.C. 247b–17) is amended— 
(1) in subsection (c)(1)— 
(A) in subparagraph (B), by striking ‘‘cer-
vical’’; 
(B) in subparagraph (C), by striking 
‘‘and’’ at the end; 
(C) in subparagraph (D) by striking 
‘‘other’’ and all that follows through ‘‘cancer.’’ 
and inserting ‘‘recommended diagnostics for 
early intervention for, and prevention of, HPV- 
associated cancers; and’’; and 
(D) by adding at the end the following: 
‘‘(E) the importance of recommended vac-
cines for prevention of HPV and HPV-associ-
ated cancers, including for males;’’; and 
(2) by amending subsection (d) to read as fol-
lows: 
‘‘(d) JOHANNA’S LAW.—
‘‘(1) NATIONAL
PUBLIC
AWARENESS
CAM-
PAIGN.— 
‘‘(A) IN
GENERAL.—The Secretary shall 
carry out a national campaign to increase the 
awareness and knowledge of health care pro-
viders 
and 
individuals 
with 
respect 
to 
gynecologic cancers, HPV, and HPV-associated 
cancers, and the importance of HPV vaccines in 
preventing HPV and HPV-associated cancers. 
‘‘(B) 
WRITTEN
MATERIALS.—Activities 
under the national campaign under subpara-
graph (A) shall include— 
‘‘(i) maintaining a supply of written 
materials that provide information to the 
public on gynecologic cancers, HPV, and 
HPV-associated cancers; and 
‘‘(ii) distributing the materials to 
members of the public upon request. 
‘‘(C) 
PUBLIC
SERVICE
ANNOUNCE-
MENTS.—Activities under the national cam-
paign under subparagraph (A) shall, in accord-
ance with applicable law and regulations, in-
clude publishing materials in digital or print 
form, public engagement, and developing and 
placing public service announcements intended
to encourage individuals to discuss with their 
physicians— 
‘‘(i) their risk of gynecologic cancers 
and HPV-associated cancers; and 
‘‘(ii) the importance of HPV vaccines 
in preventing HPV and HPV-associated 
cancers. 
‘‘(D) TARGETED POPULATIONS.—Activities 
under the national campaign under subpara-
graph (A) shall include culturally and linguis-
tically competent public service announcements 
and other forms of communication and public 
engagement under subparagraph (C) targeted 
to— 
‘‘(i) specific higher-risk populations of 
individuals based on race, ethnicity, level of 
acculturation, and family history, including 
African-American and Ashkenazi Jewish 
individuals; 
‘‘(ii) communities with high rates of 
unvaccinated individuals, including males; 
‘‘(iii) rural communities; 
‘‘(iv) populations affected by increas-
ing rates of oropharynx cancers;
‘‘(v) health care providers specializing 
in assisting survivors of sexual assault; and 
‘‘(vi) such other communities as the 
Secretary determines appropriate. 
‘‘(2) CONSULTATION.—In carrying out the na-
tional campaign under this section, the Secretary 
shall consult with— 
‘‘(A) health care providers; 
‘‘(B) nonprofit organizations (including 
gynecologic cancer organizations and organiza-
tions that represent communities and individ-
uals most affected by HPV-associated cancers 
and low vaccination rates); 
‘‘(C) State and local public health depart-
ments; and 
‘‘(D) elementary and secondary education 
organizations and institutions of higher edu-
cation. 
‘‘(3) DEMONSTRATION
PROJECTS
REGARDING 
OUTREACH AND EDUCATION STRATEGIES.— 
‘‘(A) IN GENERAL.— 
‘‘(i) PROGRAM.—The Secretary may 
carry out a program to award grants or 
contracts to public or nonprofit private en-
tities for the purpose of carrying out dem-
onstration projects to test, compare, and 
evaluate different evidence-based outreach 
and education strategies to increase the 
awareness and knowledge of women, their 
families, physicians, nurses, and other key 
health 
professionals 
with 
respect 
to 
gynecologic cancers, including with respect 
to early warning signs, risk factors, pre-
vention, screening, and treatment options. 
‘‘(ii) SCIENCE-BASED
RESOURCES.— 
In making awards under clause (i), the 
Secretary shall encourage awardees to use 
science-based resources such as the Inside 
Knowledge About Gynecologic Cancer edu-
cation campaign of the Centers for Disease 
Control and Prevention. 
‘‘(B) PREFERENCES IN AWARDING GRANTS 
OR CONTRACTS.—In making awards under sub-
paragraph (A), the Secretary shall give pref-
erence to— 
‘‘(i) applicants with demonstrated ex-
pertise in gynecologic cancer education or 
treatment or in working with groups of 
women who are at increased risk of 
gynecologic cancers; and
‘‘(ii) applicants that, in the dem-
onstration project funded by the grant or 
contract, will establish linkages between 
physicians, nurses, other key health profes-
sionals, health profession students, hos-
pitals, payers, and State health depart-
ments. 
‘‘(C) APPLICATION.—To seek a grant or 
contract under subparagraph (A), an entity 
shall submit an application to the Secretary in 
such form, in such manner, and containing such 
agreements, assurances, and information as the 
Secretary determines to be necessary to carry 
out this paragraph. 
‘‘(D) CERTAIN REQUIREMENTS.—In mak-
ing awards under subparagraph (A), the Sec-
retary shall— 
‘‘(i) make awards, as practicable, to 
not fewer than five applicants; and 
‘‘(ii) ensure that information provided 
through demonstration projects under this 
paragraph is consistent with the best avail-
able medical information. 
‘‘(E) REPORT
TO
CONGRESS.—Not later 
than 24 months after the date of the enactment